Phrmaceutical

Delhi

adminDecember 13, 2025
0

India’s Diabetes Drug Market Shifts as Ozempic Enters at ₹2200 Per Dose, 9 Points

Bagsværd (Denmark) / Delhi Ozempic Launch in India: ₹2200/Week Diabetes Injection Signals ₹10000+ Monthly GLP-1 Market Shift |What ₹1.3 Lakh…
Read More »
Market

adminOctober 26, 2025
6

QS-21: The $400000-a-Gram Solution Reshaping Global Vaccines, 13 Points

Santiago (Chile) / New York Botanical Solution Inc’s (BSI) $400,000-a-gram Innovation: How Chile’s Agri-Biotech Powerhouse is Redefining Global Vaccine and…
Read More »

Legal Disclaimer – The Profit India (Raipur) - - The content published on The Profit India (hereinafter referred to as “Website”) is intended solely for general information and public awareness. Every effort is made to ensure that the information contained on this Website is correct, complete and updated. However, The Profit India, its Founder, Editor-in-Chief, editorial board, employees, writers, contributors, partners and any other members associated with the Website (hereinafter collectively referred to as “The Profit India Team”) expressly state that the Website and its contents are provided “as is” and without any warranty of any kind, express or implied, including but not limited to, the warranties of completeness, accuracy, reliability, fitness for a particular purpose or non-infringement. By accessing, browsing or using the Website, the user acknowledges and agrees that The Profit India Team shall not be held liable under any circumstances for any direct, indirect, incidental, special, consequential or exemplary damages, claims or controversies arising out of the use, reference to, reliance on, or inability to use any information provided on the Website. All views or opinions expressed in articles, news reports, opinion pieces or any other form of content are strictly those of the respective authors and do not necessarily reflect the official policy or position of The Profit India or The Profit India Team. Users are therefore advised to verify the information contained herein with authoritative and/or primary sources before acting upon or relying on it. The Profit India reserves the right, in its sole discretion and without prior notice, to modify, add, edit or remove any content, information or material published on the Website and/or to restrict or discontinue access to the Website. Any controversy, claim or dispute arising out of or in connection with the content published on the Website or the use of the Website, including any issue relating to the interpretation, application or enforcement of this Disclaimer, shall be subject to the exclusive jurisdiction of the competent courts located at Raipur, Chhattisgarh (India). By continuing to access or use this Website, the user acknowledges that they have read, understood and agreed to abide by the terms of this Disclaimer.

Phrmaceutical

India’s Diabetes Drug Market Shifts as Ozempic Enters at ₹2200 Per Dose, 9 Points

QS-21: The $400000-a-Gram Solution Reshaping Global Vaccines, 13 Points

रायपुर : मुख्य निर्वाचन पदाधिकारी श्रीमती रीना बाबासाहेब कंगाले ने कवर्धा जिले में मतगणना स्थल का किया निरीक्षण

रायपुर : सैनिक स्कूल अंबिकापुर में कक्षा 6वीं और 9वीं में प्रवेश हेतु ऑनलाईन आवेदन 16 दिसम्बर तक

रायपुर : आदिवासियों को उनकी जमीन से उजाड़ना मानवता के खिलाफ अपराध – श्री हरिचंदन

वर्ल्ड कप की हार के बाद टीम इंडिया के ड्रेसिंग रूम में गए थे पीएम मोदी, अब आया रवि शास्त्री का बयान; क्या कहा?

24 November 2023 Rashifal : जानिए कैसा रहेगा आपका दिन, Aaj Ka Rashifal